AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation

Recruitingn/aAges 18 Years - anyAllUniversity in Zielona Góra
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational registry is to collect a curated dataset of multimodal imaging data that will serve for development of artificial-intelligence based solutions for prediction of risk and outcomes in patients with atrial fribrillation. Type of study: observational study Study Participants: Patients with atrial fibrillation or atrial flutter who undergo clinically indicated transesophageal echocardiography before catheter ablation or cardioversion. We hypothesize, that automatic analysis of video images of transthoracic echocardiography with deep learning combined with clinical data can predict the presence of left atrial appendage thrombus (LAT). Therefore, our main aim is to create and validate an artificial intelligence model to predict the presence of LAT based on automatic analysis of transthoracic echocardiography with artificial intelligence.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: \- All patients with AF or AFl in whom TEE will be performed (to assess their eligibility for cardioversion or ablation), hospitalized in a participating center during study period (all consecutive patients). Exclusion Criteria: Age\<18, lack of informed, written consent to the TEE
💊

What it tests

  • Transoesophageal echocardiography
  • Catheter ablation
📍

Where

7 sites
St. Anne Hospital
Brno, Czechia
Nowa Sol Multidyscyplinary Hospital
Nowa Sól, Poland
Medical University of Silesia
Katowice, Poland
John Paul II Hospital
Krakow, Poland
Military Institute of Medicine National Research Institute
Warsaw, Poland
National Institute of Cardiology
Warsaw, Poland
Collegium Medicum, University of Zielona Góra
Zielona Góra, Poland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy